Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|January 7, 2022
ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLCZhenlin Yang, He Tian, Fenglong Bie, et al.
Signal Transduction and Targeted Therapy|October 4, 2022
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancerYanhua Tian, Qingqing Li, Zhenlin Yang, et al.
Ebiomedicine|July 28, 2022
Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancerYing Zuo, Jia Zhong, Hua Bai, et al.
Cancer Research|January 27, 2026
Targeting LRRC15 in Cancer-Associated Fibroblasts Modifies the Extracellular Matrix and Enhances Tumor Immune Responses to Suppress Lung Cancer ProgressionLu Qi, Guohui Dang, Xinnan Ling, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 10, 2013
Ecosystem change and stability over multiple decades in the Swedish subarctic: complex processes and multiple driversTerry V Callaghan, Christer Jonasson, Tomas Thierfelder, et al.
Nature Chemical Biology|September 24, 2021
Structures of the human cholecystokinin receptors bound to agonists and antagonistsXuefeng Zhang, Chenglin He, Mu Wang, et al.
International Journal of Cancer|May 25, 2022
PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategiesZhenlin Yang, He Tian, Lin Li, et al.
Cell|March 28, 2022
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibodyCheng Li, Wuqiang Zhan, Zhenlin Yang, et al.
Signal Transduction and Targeted Therapy|November 4, 2021
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variantsZhenlin Yang, Yulu Wang, Yujia Jin, et al.
JAMA Oncology|July 21, 2022
Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical TrialJiachen Xu, Zheng Liu, Hua Bai, et al.
Pageof 17